✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals
Market Cap
₹328 Cr.
P/E
25.33

Key Ratios

Market cap
Market cap
328 Cr
PE
PE
25.33
Prom Holding
Prom Holding
56.35 %
ROE (%)
ROE (%)
26.19
ROCE (%)
ROCE (%)
43.18
Div Yield (%)
Div Yield (%)
-
Sales
Sales
309 Cr
OPM (%)
OPM (%)
9.32 %
Debt to Equity
Debt to Equity
1.18

About

Mahamaya Lifesciences manufactures pesticide formulations and supplies bulk formulations for I… Read more
Low
111
52W Range
High
151
  • Mahamaya Lifescience
  • Nova Agritech
  • Bhagiradha Chem

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

5 Yes

Positive for this company

1 Neutral

Neutral for this company

2 No

Negative for this company

9 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on Mahamaya Lifesciences Ltd. Business

Mahamaya Lifesciences specializes in the manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs). It began its journey by focusing on import and registration of vital pesticide molecules (Technical) that were not produced domestically in India. It imported these molecules after lot of product research and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. After successful registration it marketed these molecules both as technical and as value added end use formulations for both domestic manufacturers and MNCs.

Mahamaya Lifescience major competitors are Nova Agritech, Bhagiradha Chem, Dharmaj Crop Guard, Bayer CropScience, UPL, Super Crop Safe, 3B Blackbio Dx.
Market Cap of Mahamaya Lifescience is ₹321 Crs.
While the median market cap of its peers are ₹1,072 Crs.

Mahamaya Lifescience seems to be less financially stable compared to its competitors.
Altman Z score of Mahamaya Lifescience is 3.51 and is ranked 6 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material